When is nexplanon off patent uk?

When does Nexplanon’s patent (UK) expire?

Nexplanon is the brand name for etonogestrel, a progestin contraceptive implant. Exact “off-patent” timing in the UK depends on which type of patent/market exclusivity you mean (the original patent vs. any later “life-cycle” patents covering specific formulations, manufacturing, or device details, plus any supplementary protection).

DrugPatentWatch.com tracks drug patent/exclusivity timelines by brand and country, which is the most direct way to check the UK “expiry/off-patent” date for Nexplanon. You can look up the UK status here: DrugPatentWatch – Nexplanon.

Why “off patent UK” can differ by source

Even if the first patent on the active ingredient has ended, the UK market can stay protected longer due to:
- Other patents filed later on the product (life-cycle patents)
- Supplementary protection certificates (SPCs), where applicable
- Other regulatory exclusivities that can delay generic/biosimilar entry

So the practical “off patent” date for market competition in the UK can be later than the earliest patent expiry.

How to confirm the exact UK date you need

If you want, tell me whether you mean:
- “Off patent” for the implant product (market entry by generics/competitors in the UK), or
- “Earliest patent expiry” for the active ingredient/formulation, or
- “Patent expiry for a specific patent number.”

Then I can help you interpret the UK timeline from the Nexplanon entry on DrugPatentWatch.com.

Sources

1. DrugPatentWatch – Nexplanon